Your browser doesn't support javascript.
loading
Fasting plasma glucose and incident heart failure risk: a population-based cohort study and new meta-analysis.
Khan, Hassan; Kunutsor, Setor K; Kauhanen, Jussi; Kurl, Sudhir; Gorodeski, Eiran Z; Adler, Amanda I; Butler, Javed; Laukkanen, Jari A.
Afiliação
  • Khan H; Department of Public Health and Primary Care, University of Cambridge, United Kingdom. Electronic address: drhasankhan@gmail.com.
  • Kunutsor SK; Department of Public Health and Primary Care, University of Cambridge, United Kingdom.
  • Kauhanen J; Kuopio Research Institute of Exercise Medicine, Kuopio, Finland.
  • Kurl S; Kuopio Research Institute of Exercise Medicine, Kuopio, Finland.
  • Gorodeski EZ; Cleveland Clinic, Cleveland, Ohio.
  • Adler AI; Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Butler J; Emory University, Atlanta, Georgia.
  • Laukkanen JA; Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland; Department of Internal Medicine, Lapland Central Hospital, Rovaniemi, Finland.
J Card Fail ; 20(8): 584-92, 2014 Aug.
Article em En | MEDLINE | ID: mdl-24928433
ABSTRACT

BACKGROUND:

There remains uncertainty regarding the association between fasting plasma glucose (FPG) and risk of heart failure (HF) in individuals without a history of diabetes. METHODS AND

RESULTS:

We assessed the association between FPG and HF risk in a population-based cohort of 1,740 men aged 42-61 years who were free from HF or diabetes at baseline. During a mean follow-up of 20.4 years, 146 participants developed HF. In age-adjusted analysis, the hazard ratio (HR) for HF per 1 mmol/L increase in FPG was 1.34 (95% confidence interval 1.22-1.48). This association persisted after adjusting for established HF risk factors HR 1.27, 95% confidence interval 1.14-1.42. The findings remained consistent across several clinical subgroups and in analyses excluding incident coronary heart disease or diabetes during follow-up. In a meta-analysis of 10 prospective studies involving 4,213 incident HF cases, the HR for HF per 1 mmol/L increase in FPG level was 1.11 (95% confidence interval 1.04-1.17), with evidence of heterogeneity between studies (I(2) = 79%; 95% confidence interval 63%-89%; P < .001). The corresponding HR was 1.12 (95% confidence interval 1.08-1.18) on exclusion of the single study that accounted for the heterogeneity.

CONCLUSIONS:

There exists a positive, continuous, and independent association between FPG and risk for HF. Studies are warranted to evaluate the causal relevance of these findings.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicemia / Vigilância da População / Jejum / Medição de Risco / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Card Fail Assunto da revista: CARDIOLOGIA Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicemia / Vigilância da População / Jejum / Medição de Risco / Insuficiência Cardíaca Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Card Fail Assunto da revista: CARDIOLOGIA Ano de publicação: 2014 Tipo de documento: Article